🔗 Share this article

Given that America undertakes sweeping changes to its vaccination guidelines, one figure has emerged in a surprising turn: Dr. Tracy Beth Høeg, a Danish American sports medicine doctor and public health researcher who initially gained attention by casting doubt on coronavirus vaccinations during the global health crisis and has focused upon possible deaths after COVID-19 vaccination in her recent position at the FDA.

Proposed Overhauls to Pediatric Vaccine Schedule

Agency leaders were set to announce sweeping changes to the pediatric immunization program in December, aligning the US with the Danish national calendar, according to reports – a major change that would put the US out of step with a large portion of the international standard with insufficient data for benefit. The announcement has been pushed back until the new year.

In place of Vinay Prasad, Dr. Høeg is set to speak at the event. She was newly appointed temporary leader of the FDA’s CDER, the fifth individual to run the office this year.

Consolidating Power at the FDA

Høeg's temporary position could signify a closer partnership between the drug and biologics branches as Høeg and Dr. Prasad solidify control at the regulatory agency – and it signals a greater focus upon reevaluating previously authorized vaccines at the FDA.

The new acting director has repeatedly called for ending specific pediatric immunization guidelines in the US in order to be more similar to Denmark's approach, a country with nationalized medicine and a population about the size of the state of Wisconsin.

In her initial statements, she has continued to focus on vaccines – typically the purview of Dr. Prasad, chief of the FDA’s vaccine center – as opposed to pharmaceutical oversight.

Questions Over Background

Dr. Høeg has no apparent track record in medication creation, approval processes or management, which has been typical for former leaders of the Center for Biologics Evaluation and Research. She has been employed at the FDA as a key advisor to the agency head and the vaccine center since earlier this year.

“It seems she lacks to have the necessary background” for leading the CDER, stated a neurologist and psychiatrist. “She has not conducted a scientific study. She is not versed in running a major agency. She is not an expert in drug approvals.”

Past directors of CBER would “grasp laws and regulations and the science of drug development”, said Janet Woodcock. “Clearly, she lacks the sort of resume that prior appointees who led CBER have had.”

This division has an vast range of responsibilities at the FDA, she stated.

“Everybody just zeroes in on the new drug program, but the off-patent medication office clears a multitude of off-brand pharmaceuticals. There is also a biosimilars division, over-the-counter program and more, and all of those have to be managed,” Woodcock noted. “The responsibility you overlook, that is precisely what that I always told people is going to cause problems.”

Furthermore, a substantial administrative element to the position, which supervises more than 5,000 employees. “It is a enormous administrative position, if you perform it correctly,” the former official said.

Response and Contentious Policies

Regarding concerns about Høeg’s qualifications and whether this assignment signifies increased cooperation among regulatory chiefs on vaccines, a press secretary said that the “concerns are based on inaccurate assumptions”.

“Her resume aligns with the responsibilities of her job,” the representative said, noting the period Dr. Høeg spent guiding the agency head on “pharmaceutical safety and regulatory science, including predictive safety algorithms and immunization monitoring”.

As acting director, Høeg inherits the agency head's controversial expedited review system, a contentious one-day medication authorization process that allegedly worried her preceding directors. “How are these therapies being picked for this fast-track system? Who takes the calls?” Dr. Howard said. “There is a lot of lack of transparency occurring at the agency right now.”

In general, he stated, “the agency looks to be trending towards laxer regulations of most medications, aside from immunizations.”

Documented Past Work on Immunizations

Concerning immunizations, Høeg has a more documented, if concerning, history, critics said. She published a research paper using unconfirmed volunteer-provided data to assess the incidence of heart inflammation following Covid vaccination. She advised the Florida top health official Dr. Joseph Ladapo, who allegedly have modified findings to imply COVID-19 vaccines are pose a greater threat than they are.

Included in her “desired changes” for the current government included altering rules for new vaccines and ending “optional” vaccines, she stated after the election on a audio program. At the agency, Høeg has allegedly floated the idea of excluding adolescent males from receiving COVID-19 vaccines.

“She is an complete ideologue who starts off with her conclusions and tailors the evidence to retrofit the science in a highly disingenuous, untruthful fashion,” Dr. Howard argued.

Consolidating Power and a “Revenge Tour”

Høeg joined other dissenters, {like|